Oncology News

• KRAS Mutation Predicts Pembrolizumab Response in NSCLC A new study, published as a preprint, reported a better way to predict if patients with metastatic nonsmall cell lung cancer will respond to pembrolizumab.
  First Look, December 02, 2021
• RSNA 2021 Older Anticoagulants Linked to Brain Hemorrhage After Trauma Consider repeat head CT scans for trauma patients who are taking any anticoagulants or antiplatelet medications concurrently with aspirin, researchers say.
  Medscape Medical News, December 02, 2021
• Cancer Hospitals Fail to Reveal Prices: 'Not Always Shopable' The Community Oncology Alliance was among the groups that did their own research in support of a plan to boost the federal penalties for hospitals that fail to meet standards for revealing prices.
  Medscape Medical News, December 02, 2021
• 10 Changes to Keep Clinicians in the Workforce in a Pandemic Doctors make checklist of low-cost action items to start addressing a wave of providers leaving medicine.
  Medscape Medical News, December 02, 2021
• Large Analysis Confirms Safety of Nipple-Sparing Mastectomy Overall survival and breast cancer-specific survival were similar for women undergoing nipple-sparing mastectomy and those receiving a total mastectomy.
  Medscape Medical News, December 02, 2021
• Differences in Response to Immunotherapy in Men vs Women Women with advanced melanoma had a twofold increase in mortality risk, compared with male counterparts, when treated with combination checkpoint inhibition.
  Medscape Medical News, December 02, 2021
• FDA Rejects Novel Agent for Chemo-induced Neutropenia The agency said that more clinical data is needed for the novel agent plinabulin for use in the prevention of chemotherapy-induced neutropenia.
  Medscape Medical News, December 02, 2021
• The Hidden Cost of Prostatectomy: Patient Regret Men with localized prostate cancer who opt for surgery instead of surveillance are more than twice as likely to regret their decision.
  Medscape Medical News, December 01, 2021
• Alert FDA Approves Time-Saving Combo for R/r Multiple Myeloma The US Food and Drug Administration this week approved daratumumab + hyaluronidase-fihj and carfilzomib plus dexamethasone – a combination that features quickly administered subcutaneous daratumumab.
  FDA Approvals, December 01, 2021
• Majority of Patients Prefer In-Person Visits to Telehealth: Survey But two thirds of respondents are willing to do at least some video visits, and most people with telehealth experience would do it again.
  WebMD Health News, December 01, 2021
• Cancer Survivors Want Their Sexy Back…but Are Afraid to Ask Lack of attention to sexual health threatens quality of life for cancer survivors. 'Oncologists need to recognize that this is an issue,' says one.
  Medscape Medical News, December 01, 2021
• Novel Agent May Be Game-Changer in Rare Genetic Disease Patients with von Hippel-Lindau face a high risk of renal cell carcinoma and other cancers, which often require multiple surgeries. A new drug may change the course of the disease.
  Medscape Medical News, December 01, 2021
• 'Top' Surgery for Trans Youth: Advance or Dangerous Medicine? Doctor uses historical examples of questionable medical interventions to draw parallels with gender-affirming, so-called masculinizing chest surgery performed on many transgender youth today.
  Medscape Medical News, December 01, 2021
• ASH 2021 ASH Meeting: Diversity, Inclusion, Immunotherapy, and COVID-19 The American Society for Hematology 2021 Annual Meeting will be a hybrid affair packed with great science, say the meeting organizers.
  Medscape Medical News, December 01, 2021
• Radiosurgery Improves Meningioma Control Over Active Surveillance Watchful waiting may not always be the best treatment choice for skull base meningiomas, according to a new study.
  Medscape Medical News, December 01, 2021
• Can Aspirin Prolong Survival in Patients With NSCLC? A new study shows that people with inoperable non-small cell lung cancer who took the cheap painkiller survived longer, but questions linger.
  Medscape Medical News, December 01, 2021
• Alert After Doc Uproar, NCCN Reverses Prostate Cancer Guidance The cancer organization today largely reinstated its former advice that men with low-risk prostate cancer be offered active surveillance as the lone 'preferred' initial treatment option.
  News Alerts, November 30, 2021
• Sickle Cell Raises Risk for Stillbirth Sickle cell trait and sickle cell disease may be associated with an increased risk for stillbirth, research shows.
  Medscape Medical News, November 30, 2021
• Wearable Fitness Trackers Could Detect COVID Before You Do Scientists designed an algorithm that detected 4 out of 5 infections in a new study.
  WebMD Health News, November 30, 2021
• New Trials in GI Cancers (Non-CRC): Could Your Patient Benefit? Late-phase clinical trials that are currently recruiting patients with noncolorectal gastrointestinal (GI) cancers could be of benefit to your patients.
  Medscape Medical News, November 30, 2021